{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:45:45Z","timestamp":1790019945118,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute, NIH","doi-asserted-by":"crossref","award":["R37 CA276928"],"award-info":[{"award-number":["R37 CA276928"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11864-025-01341-5","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T05:21:13Z","timestamp":1758691273000},"page":"920-927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Care of Older Adults with Acute Myeloid Leukemia: The Role of Geriatric Assessment"],"prefix":"10.1007","volume":"26","author":[{"given":"Ojbindra","family":"KC","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz","family":"Ellithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2513-0533","authenticated-orcid":false,"given":"Vijaya Raj","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"4","key":"1341_CR1","first-page":"379","volume":"19","author":"JF Yamamoto","year":"2008","unstructured":"Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the united States by subtype and demographic characteristics, 1997\u20132002. Cancer Causes Control CCC. 2008;19(4):379\u201390.","journal-title":"Cancer Causes Control CCC"},{"key":"1341_CR2","unstructured":"SEER [Internet]. [cited 2025 Apr 26]. Acute Myeloid Leukemia - Cancer Stat Facts. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html. Accessed 26 Apr 2025"},{"issue":"2","key":"1341_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.seminoncol.2003.12.024","volume":"31","author":"R Yancik","year":"2004","unstructured":"Yancik R, Ries LAG. Cancer in older persons: an international issue in an aging world. Semin Oncol. 2004;31(2):128\u201336.","journal-title":"Semin Oncol"},{"issue":"1","key":"1341_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/10428194.2017.1323275","volume":"59","author":"VR Bhatt","year":"2018","unstructured":"Bhatt VR, Gundabolu K, Koll T, Maness LJ. Initial therapy for acute myeloid leukemia in older patients: principles of care. Leuk Lymphoma. 2018;59(1):29\u201341.","journal-title":"Leuk Lymphoma"},{"issue":"23","key":"1341_CR5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1182\/blood.2019001299","volume":"134","author":"HD Klepin","year":"2019","unstructured":"Klepin HD. Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice. Blood. 2019;134(23):2005\u201312.","journal-title":"Blood"},{"issue":"1","key":"1341_CR6","first-page":"19","volume":"5","author":"CAJ Devons","year":"2002","unstructured":"Devons CAJ. Comprehensive geriatric assessment: making the most of the aging years. Curr Opin Clin Nutr Metab Care. 2002;5(1):19\u201324.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"24","key":"1341_CR7","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","volume":"32","author":"H Wildiers","year":"2014","unstructured":"Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen MLG, Extermann M, et al. International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32(24):2595\u2013603.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"33","key":"1341_CR8","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1200\/JCO.2011.35.7525","volume":"29","author":"RB Walter","year":"2011","unstructured":"Walter RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA, et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(33):4417\u201323.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"21","key":"1341_CR9","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1182\/blood-2012-12-471680","volume":"121","author":"HD Klepin","year":"2013","unstructured":"Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Pardee TS, et al. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood. 2013;121(21):4287\u201394.","journal-title":"Blood"},{"issue":"10","key":"1341_CR10","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/j.1532-5415.2011.03614.x","volume":"59","author":"HD Klepin","year":"2011","unstructured":"Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Ellis LR, et al. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc. 2011;59(10):1837\u201346.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1341_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood.2023022611","volume":"143","author":"VR Bhatt","year":"2024","unstructured":"Bhatt VR, Uy GL, Klepin HD. Determining treatment tolerance and fitness for intensive chemotherapy in older adults with AML: a call to action. Blood. 2024;143(6):483\u20137.","journal-title":"Blood"},{"issue":"25","key":"1341_CR12","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","volume":"29","author":"A Hurria","year":"2011","unstructured":"Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(25):3457\u201365.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"20","key":"1341_CR13","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1200\/JCO.2015.65.4327","volume":"34","author":"A Hurria","year":"2016","unstructured":"Hurria A, Mohile S, Gajra A, Klepin H, Muss H, Chapman A, et al. Validation of a prediction tool for chemotherapy toxicity in older adults with Cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34(20):2366\u201371.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"22","key":"1341_CR14","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol Off J Am Soc Clin Oncol. 2018;36(22):2326\u201347.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"1341_CR15","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1182\/blood.2021013671","volume":"139","author":"GJ Min","year":"2022","unstructured":"Min GJ, Cho BS, Park SS, Park S, Jeon YW, Shin SH, et al. Geriatric assessment predicts nonfatal toxicities and survival for intensively treated older adults with AML. Blood. 2022;139(11):1646\u201358.","journal-title":"Blood"},{"issue":"12","key":"1341_CR16","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/bloodadvances.2021006872","volume":"6","author":"EK Ritchie","year":"2022","unstructured":"Ritchie EK, Klepin HD, Storrick E, Major B, Le-Rademacher J, Wadleigh M, et al. Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101. Blood Adv. 2022;6(12):3812\u201320.","journal-title":"Blood Adv"},{"key":"1341_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ctrv.2019.04.001","volume":"75","author":"V Raj Bhatt","year":"2019","unstructured":"Bhatt VR. Personalizing therapy for older adults with acute myeloid leukemia: role of geriatric assessment and genetic profiling. Cancer Treat Rev. 2019;75:52\u201361.","journal-title":"Cancer Treat Rev"},{"issue":"10314","key":"1341_CR18","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile SG, Mohamed MR, Xu H, Culakova E, Loh KP, Magnuson A, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet Lond Engl. 2021;398(10314):1894\u2013904.","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"1341_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/jamaoncol.2019.4728","volume":"6","author":"SG Mohile","year":"2020","unstructured":"Mohile SG, Epstein RM, Hurria A, Heckler CE, Canin B, Culakova E, et al. Communication with older patients with Cancer using geriatric assessment: A Cluster-Randomized clinical trial from the National Cancer Institute community oncology research program. JAMA Oncol. 2020;6(2):196\u2013204.","journal-title":"JAMA Oncol"},{"issue":"11","key":"1341_CR20","doi-asserted-by":"publisher","first-page":"e214158","DOI":"10.1001\/jamaoncol.2021.4158","volume":"7","author":"D Li","year":"2021","unstructured":"Li D, Sun CL, Kim H, Soto-Perez-de-Celis E, Chung V, Koczywas M, et al. Geriatric Assessment-Driven intervention (GAIN) on Chemotherapy-Related toxic effects in older adults with cancer: A randomized clinical trial. JAMA Oncol. 2021;7(11):e214158.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1341_CR21","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/jamaoncol.2021.0848","volume":"7","author":"PS Hall","year":"2021","unstructured":"Hall PS, Swinson D, Cairns DA, Waters JS, Petty R, Allmark C, et al. Efficacy of Reduced-Intensity chemotherapy with oxaliplatin and capecitabine on quality of life and Cancer control among older and frail patients with advanced gastroesophageal Cancer. JAMA Oncol. 2021;7(6):869\u201377.","journal-title":"JAMA Oncol"},{"issue":"5","key":"1341_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jgo.2018.11.005","volume":"10","author":"V Raj Bhatt","year":"2019","unstructured":"Raj Bhatt V. Understanding patients\u2019 values and priorities in selecting cancer treatments: developing a therapy preference scale. J Geriatr Oncol. 2019;10(5):677\u20139.","journal-title":"J Geriatr Oncol"},{"issue":"7","key":"1341_CR23","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/ajh.27694","volume":"100","author":"VR Bhatt","year":"2025","unstructured":"Bhatt VR, Wichman CS, Koll TT, Fisher AL, Wildes TM, Haddadin M, et al. A Phase II Trial of Geriatric Assessment-Guided Selection of Treatment Intensity in Older Adults With AML. Am J Hematol. 2025;100(7):1163\u201372.","journal-title":"Am J Hematol."},{"issue":"10","key":"1341_CR24","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/jgs.14301","volume":"64","author":"HD Klepin","year":"2016","unstructured":"Klepin HD, Tooze JA, Pardee TS, Ellis LR, Berenzon D, Mihalko SL, et al. Effect of intensive chemotherapy on physical, cognitive, and emotional health of older adults with acute myeloid leukemia. J Am Geriatr Soc. 2016;64(10):1988\u201395.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1341_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jgo.2015.04.002","volume":"6","author":"SMH Alibhai","year":"2015","unstructured":"Alibhai SMH, Breunis H, Timilshina N, Brignardello-Petersen R, Tomlinson G, Mohamedali H, et al. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age. J Geriatr Oncol. 2015;6(4):262\u201371.","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"1341_CR26","doi-asserted-by":"publisher","first-page":"101676","DOI":"10.1016\/j.jgo.2023.101676","volume":"15","author":"VR Bhatt","year":"2024","unstructured":"Bhatt VR, Wichman C, Koll TT, Fisher AL, Wildes TM, Berger A, et al. Longitudinal changes in cognitive and physical function and health-related quality of life in older adults with acute myeloid leukemia. J Geriatr Oncol. 2024;15(1):101676.","journal-title":"J Geriatr Oncol"},{"issue":"5","key":"1341_CR27","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s12325-020-01310-4","volume":"37","author":"D Capelli","year":"2020","unstructured":"Capelli D, Saraceni F, Fiorentini A, Chiarucci M, Menotti D, Poloni A, et al. Feasibility and outcome of a phase II study of intensive induction chemotherapy in 91 elderly patients with AML evaluated using a simplified multidimensional geriatric assessment. Adv Ther. 2020;37(5):2288\u2013302.","journal-title":"Adv Ther"},{"issue":"8","key":"1341_CR28","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3324\/haematol.2014.103655","volume":"99","author":"LS Muffly","year":"2014","unstructured":"Muffly LS, Kocherginsky M, Stock W, Chu Q, Bishop MR, Godley LA, et al. Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica. 2014;99(8):1373\u20139.","journal-title":"Haematologica"},{"key":"1341_CR29","doi-asserted-by":"publisher","first-page":"2025015793","DOI":"10.1182\/bloodadvances.2025015793","volume":"18","author":"ML Sorror","year":"2025","unstructured":"Sorror ML, Saber W, Logan BR, Geller NL, Bellach A, Kou J, et al. Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704. Blood Adv. 2025;18:2025015793. https:\/\/doi.org\/10.1182\/bloodadvances.2025015793.","journal-title":"Blood Adv"},{"issue":"Supplement 1","key":"1341_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1182\/blood-2024-194414","volume":"144","author":"M Sorror","year":"2024","unstructured":"Sorror M, Saber W, Logan BR, Geller N, Bellach A, Kou J, et al. The composite health risk assessment model (CHARM) predicts risks of toxicities, functional and cognitive decline among survivors of allogeneic hematopoietic cell transplantation (allo-HCT): A prospective BMT-CTN study 1704. Blood. 2024;144(Supplement 1):685.","journal-title":"Blood"},{"issue":"11","key":"1341_CR31","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s11912-024-01600-y","volume":"26","author":"VR Bhatt","year":"2024","unstructured":"Bhatt VR. Developing a National study that integrates the geriatric assessment into the care of older patients with myeloid malignancies. Curr Oncol Rep. 2024;26(11):1349\u201354.","journal-title":"Curr Oncol Rep"},{"issue":"26","key":"1341_CR32","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.23.00933","volume":"41","author":"W Dale","year":"2023","unstructured":"Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic Cancer therapy: ASCO guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2023;41(26):4293\u2013312.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"1341_CR33","doi-asserted-by":"publisher","first-page":"e100044","DOI":"10.1200\/EDBK_100044","volume":"44","author":"FC Diaz","year":"2024","unstructured":"Diaz FC, Hamparsumian A, Loh KP, Verduzco-Aguirre H, Abdallah M, Williams GR, et al. Geriatric oncology: A 5-Year strategic plan. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet. 2024;44(3):e100044.","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet"},{"issue":"12","key":"1341_CR34","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra2307160","volume":"390","author":"GS Ginsburg","year":"2024","unstructured":"Ginsburg GS, Picard RW, Friend SH. Key issues as wearable digital health technologies enter clinical care. N Engl J Med. 2024;390(12):1118\u201327.","journal-title":"N Engl J Med"},{"key":"1341_CR35","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.1182\/blood-2023-181156","volume":"142","author":"AE Rosko","year":"2023","unstructured":"Rosko AE, Elsaid M, Wall SA, Mims A, Woyach JA, Presley C, et al. Molecular biomarkers of aging to predict clinical frailty in newly diagnosed hematologic malignancy. Blood. 2023;142:5164.","journal-title":"Blood"},{"issue":"8","key":"1341_CR36","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.clinph.2019.04.714","volume":"130","author":"DE Anderson","year":"2019","unstructured":"Anderson DE, Bhatt VR, Schmid K, Holstein SA, Lunning M, Berger AM, et al. Neurophysiological evidence of impaired attention and working memory in untreated hematologic cancer patients. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2019;130(8):1243\u201352.","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"issue":"16suppl","key":"1341_CR37","doi-asserted-by":"publisher","first-page":"12010","DOI":"10.1200\/JCO.2023.41.16_suppl.12010","volume":"41","author":"HD Klepin","year":"2023","unstructured":"Klepin HD, Isom S, Callahan KE, Pajewski N, Topaloglu U, Wagner LI, et al. Frailty status determined by an electronic health record embedded frailty index and hospitalization risk among older adults following the initiation of cancer chemotherapy. J Clin Oncol. 2023;41(16suppl):12010\u201312010.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1341_CR38","doi-asserted-by":"publisher","first-page":"afad219","DOI":"10.1093\/ageing\/afad219","volume":"52","author":"T Shiwani","year":"2023","unstructured":"Shiwani T, Relton S, Evans R, Kale A, Heaven A, Clegg A, et al. New horizons in artificial intelligence in the healthcare of older people. Age Ageing. 2023;52(12):afad219.","journal-title":"Age Ageing"},{"issue":"2","key":"1341_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3324\/haematol.2012.067892","volume":"98","author":"B Deschler","year":"2013","unstructured":"Deschler B, Ihorst G, Platzbecker U, Germing U, M\u00e4rz E, de Figuerido M, et al. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica. 2013;98(2):208\u201316.","journal-title":"Haematologica"},{"key":"1341_CR40","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1182\/blood-2019-123598","volume":"134","author":"RL Olin","year":"2019","unstructured":"Olin RL, Fretham C, Pasquini MC, Arora M, Bhatt VR, Derman B, et al. Cognitive impairment is associated with inferior survival and increased Non-Relapse mortality in older allogeneic hematopoietic cell transplant (alloHCT) recipients: A multicenter retrospective study. Blood. 2019;134:4606.","journal-title":"Blood"},{"issue":"23","key":"1341_CR41","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1182\/blood.2020005498","volume":"136","author":"M Saad","year":"2020","unstructured":"Saad M, Loh KP, Tooze JA, Pardee TS, Ellis LR, Powell BL, et al. Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia. Blood. 2020;136(23):2715\u20139.","journal-title":"Blood"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01341-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-025-01341-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01341-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:35:39Z","timestamp":1759995339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-025-01341-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1341"],"URL":"https:\/\/doi.org\/10.1007\/s11864-025-01341-5","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"24 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VRB reports participating in the Safety Monitoring Committee for Protagonist, serving as a member of the National Comprehensive Cancer Network Acute Myeloid Leukemia Panel, as an Associate Editor for the journal, Current Problems in Cancer, and as a contributor for BMJ Best Practice, and receiving consulting fees from Jazz, research funding (institutional) from Cynata Therapeutics, MEI Pharma, Actinium Pharmaceutical, Sanofi U.S. Services, Abbvie, Pfizer, Incyte, Jazz, and National Marrow Donor Program, and drug support (institutional) from Chimerix for a trial. There are no conflicts for other authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the author have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}